The global portable oxygen concentrators market size was valued at USD 2.2 billion in 2022. The market is projected to grow from USD 2.2 billion in 2022 to USD 4.5 billion by 2030, exhibiting a CAGR of 10.50% during the forecast period.

Read Comprehensive Overview of Report @
One of the main factors fueling the market's expansion is the rising frequency of respiratory illnesses, including sleep apnea and asthma. Additionally, the aging population, which is more prone to certain illnesses, and the increased need for convenient portable devices drive the market. Following this, the demand for POCs in healthcare facilities has significantly increased as the coronavirus illness (COVID-19) pandemic spreads across the globe. These devices are necessary to maintain a sufficient oxygen concentration in patients with pre-existing asthma, chronic obstructive pulmonary disease (COPD), and other lung conditions. 

Global Market for Portable Oxygen Concentrators is Being Augmented by COPD Incidence Rise

Emphysema, chronic bronchitis, refractory asthma, and other progressive lung diseases are referred to as chronic obstructive pulmonary disease (COPD). An ongoing oxygen supply is necessary for patients with severe COPD. However, these could be the first indications of COPD. Symptoms like increased breathlessness and coughing are frequently disregarded as a normal part of aging. Chronic obstructive pulmonary disease (COPD), the third-leading cause of death globally in 2019, affected more than 65 million people, according to the World Health Organization (WHO). 

Read More News :